Literature DB >> 11033829

Clinical trials referral resource. Current clinical trials administering the antiangiogenesis agent SU5416.

L E Via, R E Gore-Langton, J M Pluda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11033829

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  2 in total

1.  Plasminogen kringle 5 reduces vascular leakage in the retina in rat models of oxygen-induced retinopathy and diabetes.

Authors:  S X Zhang; J Sima; C Shao; J Fant; Y Chen; B Rohrer; G Gao; J-x Ma
Journal:  Diabetologia       Date:  2003-12-10       Impact factor: 10.122

Review 2.  Current approaches to novel therapeutics in pancreatic cancer.

Authors:  Corina E Akerele; Irina Rybalova; Howard L Kaufman; Sridhar Mani
Journal:  Invest New Drugs       Date:  2003-02       Impact factor: 3.850
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.